2024 Q4 Form 10-Q Financial Statement
#000149315224045236 Filed on November 14, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q4 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $3.541M | ||
YoY Change | 1299.6% | ||
% of Gross Profit | |||
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $3.541M | ||
YoY Change | 1299.6% | ||
Operating Profit | -$8.981M | ||
YoY Change | 2923.89% | ||
Interest Expense | $480.0K | ||
YoY Change | -81.91% | ||
% of Operating Profit | |||
Other Income/Expense, Net | -$1.111M | -$225.0K | |
YoY Change | -495.5% | -148.18% | |
Pretax Income | -$3.286M | ||
YoY Change | -214.57% | ||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$10.09M | -$3.286M | |
YoY Change | -2687.77% | -214.57% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.22 | ||
Diluted Earnings Per Share | -$0.22 | -$0.29 | |
COMMON SHARES | |||
Basic Shares Outstanding | 47.94M shares | 47.70M shares | |
Diluted Shares Outstanding | 45.17M shares |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2023 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $22.00K | ||
YoY Change | -78.22% | ||
Cash & Equivalents | $1.587M | $22.00K | |
Short-Term Investments | |||
Other Short-Term Assets | $14.00K | ||
YoY Change | 75.0% | ||
Inventory | |||
Prepaid Expenses | $14.00K | ||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $3.307M | $36.00K | |
YoY Change | 4033.82% | -66.97% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $14.83K | $1.968K | |
YoY Change | -99.7% | -99.96% | |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | ||
YoY Change | -100.0% | ||
Other Assets | $43.70M | ||
YoY Change | |||
Total Long-Term Assets | $2.070M | $43.70M | |
YoY Change | -95.14% | -85.66% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $3.307M | $36.00K | |
Total Long-Term Assets | $2.070M | $43.70M | |
Total Assets | $5.377M | $43.74M | |
YoY Change | -87.41% | -85.65% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $6.494M | $64.00K | |
YoY Change | 162254.13% | -14.67% | |
Accrued Expenses | $4.327M | ||
YoY Change | 43.47% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $383.8K | $3.481M | |
YoY Change | -85.03% | 343.44% | |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $11.01M | $7.872M | |
YoY Change | 191.7% | 103.1% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | ||
YoY Change | |||
Other Long-Term Liabilities | $10.84M | ||
YoY Change | -1.19% | ||
Total Long-Term Liabilities | $10.84M | ||
YoY Change | -1.19% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $11.01M | $7.872M | |
Total Long-Term Liabilities | $10.84M | ||
Total Liabilities | $18.68M | $18.71M | |
YoY Change | 29.85% | 26.05% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$43.05M | -$18.67M | |
YoY Change | 200.89% | 26.73% | |
Common Stock | $4.573K | $4.023K | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$13.30M | -$18.67M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $5.377M | $43.74M | |
YoY Change | -87.41% | -85.65% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$10.09M | -$3.286M | |
YoY Change | -2687.77% | -214.57% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$296.0K | ||
YoY Change | -44.26% | ||
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$600.0K | ||
YoY Change | |||
Cash From Investing Activities | -$600.0K | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 917.0K | ||
YoY Change | 138.18% | ||
NET CHANGE | |||
Cash From Operating Activities | -296.0K | ||
Cash From Investing Activities | -600.0K | ||
Cash From Financing Activities | 917.0K | ||
Net Change In Cash | 21.00K | ||
YoY Change | -114.38% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | -$296.0K | ||
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001831979 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1739280 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-5074276 | usd |
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2023Q4 | SDST |
Promissory Notes Issued
PromissoryNotesIssued
|
usd | |
CY2023Q4 | us-gaap |
Other Long Term Investments
OtherLongTermInvestments
|
usd | |
CY2024Q3 | SDST |
Simple Agreement For Future Equity Notes
SimpleAgreementForFutureEquityNotes
|
usd | |
CY2023Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
usd | |
CY2023Q4 | SDST |
Earnout Liability
EarnoutLiability
|
usd | |
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
shares | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
usd | |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
usd | |
us-gaap |
Revenues
Revenues
|
usd | ||
us-gaap |
Revenues
Revenues
|
usd | ||
CY2024Q3 | SDST |
Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
|
usd | |
CY2024Q3 | SDST |
Other Transaction Costs
OtherTransactionCosts
|
usd | |
SDST |
Other Transaction Costs
OtherTransactionCosts
|
usd | ||
CY2023Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
usd | |
us-gaap |
Interest Income Other
InterestIncomeOther
|
usd | ||
CY2023Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
usd | |
CY2023Q3 | SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
usd | |
SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
usd | ||
CY2023Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
usd | ||
CY2023Q3 | SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
usd | |
SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
usd | ||
CY2024Q3 | SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
usd | |
CY2023Q3 | SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
usd | |
SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
usd | ||
CY2024Q3 | SDST |
Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
|
usd | |
CY2023Q3 | SDST |
Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
|
usd | |
SDST |
Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
|
usd | ||
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
CY2023Q1 | SDST |
Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
|
usd | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
usd | |
CY2023Q1 | SDST |
Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
|
usd | |
CY2023Q4 | SDST |
Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
|
usd | |
CY2024Q3 | SDST |
Adjustments To Additional Paid In Capital Earnout Shares
AdjustmentsToAdditionalPaidInCapitalEarnoutShares
|
usd | |
CY2023Q4 | SDST |
Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
|
usd | |
SDST |
Adjustments To Additional Paid In Capital Earnout Shares
AdjustmentsToAdditionalPaidInCapitalEarnoutShares
|
usd | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
usd | ||
SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
usd | ||
SDST |
Fair Value Of Simple Agreement For Future Equity Issuance Costs
FairValueOfSimpleAgreementForFutureEquityIssuanceCosts
|
usd | ||
SDST |
Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
|
usd | ||
SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
usd | ||
SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
usd | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
usd | ||
SDST |
Safe Notes Issuance Costs
SafeNotesIssuanceCosts
|
usd | ||
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
usd | ||
us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
usd | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
usd | ||
SDST |
Payments To Promissory Note Issued
PaymentsToPromissoryNoteIssued
|
usd | ||
SDST |
Proceeds From Investor Deposits
ProceedsFromInvestorDeposits
|
usd | ||
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
usd | ||
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | ||
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
usd | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
usd | ||
SDST |
Payment Of Safe Note Issuance Cost To Related Parties
PaymentOfSafeNoteIssuanceCostToRelatedParties
|
usd | ||
us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
usd | ||
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
usd | ||
SDST |
Proceeds From Business Combination And Issuance Of Pipe Shares
ProceedsFromBusinessCombinationAndIssuanceOfPIPEShares
|
usd | ||
SDST |
Repayment Of Sponsor Promissory Notes
RepaymentOfSponsorPromissoryNotes
|
usd | ||
SDST |
Repurchase Of Unvested Shares
RepurchaseOfUnvestedShares
|
usd | ||
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
usd | |
SDST |
Unpaid Deferred Transaction Cost
UnpaidDeferredTransactionCost
|
usd | ||
SDST |
Conversion Of Legacy Safe Notes
ConversionOfLegacySafeNotes
|
usd | ||
SDST |
Conversion Of Legacy Convertible Notes
ConversionOfLegacyConvertibleNotes
|
usd | ||
SDST |
Sponsor Earn Out Share Liability
SponsorEarnOutShareLiability
|
usd | ||
SDST |
Issuance Of Common Stock To Sponsor
IssuanceOfCommonStockToSponsor
|
usd | ||
SDST |
Net Liabilities Assumed Upon Closing Of Business Combination
NetLiabilitiesAssumedUponClosingOfBusinessCombination
|
usd | ||
SDST |
Issuance Of Common Stock To Non Redeeming Shareholders
IssuanceOfCommonStockToNonRedeemingShareholders
|
usd | ||
SDST |
Unpaid Safe Note Issuance Costs
UnpaidSafeNoteIssuanceCosts
|
usd | ||
SDST |
Unpaid Preacquisition Capital Project Cost
UnpaidPreacquisitionCapitalProjectCost
|
usd | ||
SDST |
Antidilutive Securities Excluded From Computation Of Restricted Stock Options
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockOptions
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Restricted Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockUnits
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Performance Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfPerformanceStockUnits
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Sponsor Earnout Shares Note3
AntidilutiveSecuritiesExcludedFromComputationOfSponsorEarnoutSharesNote3
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Sponsor Earnout Shares Note3
AntidilutiveSecuritiesExcludedFromComputationOfSponsorEarnoutSharesNote3
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Public Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPublicWarrants
|
shares | ||
SDST |
Antidilutive Securities Excluded From Computation Of Private Placement Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPrivatePlacementWarrants
|
shares | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
|
shares | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
|||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
|
shares | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
|
|||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
shares | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
|||
CY2023Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
shares | |
CY2023Q4 | SDST |
Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
|
usd | |
CY2024Q3 | SDST |
Consulting Expenses
ConsultingExpenses
|
usd | |
SDST |
Consulting Expenses
ConsultingExpenses
|
usd | ||
CY2024Q3 | us-gaap |
Other Expenses
OtherExpenses
|
usd | |
CY2023Q3 | us-gaap |
Other Expenses
OtherExpenses
|
usd | |
us-gaap |
Other Expenses
OtherExpenses
|
usd | ||
CY2024Q3 | SDST |
Consulting And Other Expense
ConsultingAndOtherExpense
|
usd | |
SDST |
Consulting And Other Expense
ConsultingAndOtherExpense
|
usd | ||
CY2024Q3 | us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
usd | |
CY2023Q3 | us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
usd | |
us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
usd | ||
CY2023Q4 | SDST |
Advisory Fees
AdvisoryFees
|
usd | |
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39875 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
STARDUST POWER INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
99-3863616 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
15 E. Putnam Ave | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 378 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Greenwich | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CT | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
06830 | ||
dei |
City Area Code
CityAreaCode
|
(800) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
742-3095 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
47936140 | shares |
dei |
Entity Listing Par Value Per Share
EntityListingParValuePerShare
|
0.0001 | ||
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1587086 | usd |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1271824 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1024850 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
426497 | usd |
CY2024Q3 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
199724 | usd |
CY2023Q4 | us-gaap |
Deferred Costs Current
DeferredCostsCurrent
|
1005109 | usd |
CY2024Q3 | SDST |
Promissory Notes Issued
PromissoryNotesIssued
|
495397 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
3307057 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2703430 | usd |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
14830 | usd |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1968 | usd |
CY2024Q3 | SDST |
Pre Acquistion Land Cost
PreAcquistionLandCost
|
1937487 | usd |
CY2023Q4 | SDST |
Pre Acquistion Land Cost
PreAcquistionLandCost
|
100000 | usd |
CY2024Q3 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
67562 | usd |
CY2023Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
218556 | usd |
CY2024Q3 | us-gaap |
Other Long Term Investments
OtherLongTermInvestments
|
50000 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
5376936 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
3023954 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
6494165 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1256792 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
4129258 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
208107 | usd |
CY2024Q3 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
4408 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
|
2990 | usd |
CY2024Q3 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
383797 | usd |
CY2023Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
72967 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11011628 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1540856 | usd |
CY2023Q4 | SDST |
Simple Agreement For Future Equity Notes
SimpleAgreementForFutureEquityNotes
|
5212200 | usd |
CY2024Q3 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
4693859 | usd |
CY2024Q3 | SDST |
Earnout Liability
EarnoutLiability
|
2972800 | usd |
CY2024Q3 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
3259 | usd |
CY2023Q4 | us-gaap |
Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
|
5660 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
18681546 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
6758716 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
700000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
69033000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47872445 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47872445 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41499772 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41499772 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
4573 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
4023 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
29741789 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
54800 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-43050972 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-3793585 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13304610 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5376936 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3023954 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8980965 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
778455 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
11483389 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1902653 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8980965 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-778455 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-11483389 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1902653 | usd | |
CY2023Q3 | SDST |
Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
|
29655 | usd |
SDST |
Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
|
466302 | usd | |
CY2023Q3 | SDST |
Other Transaction Costs
OtherTransactionCosts
|
35690 | usd |
SDST |
Other Transaction Costs
OtherTransactionCosts
|
452519 | usd | |
CY2024Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
3397 | usd |
us-gaap |
Interest Income Other
InterestIncomeOther
|
3397 | usd | |
CY2024Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
8558 | usd |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
10637 | usd | |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
7111 | usd | |
CY2024Q3 | SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
1636100 | usd |
SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
1636100 | usd | |
CY2024Q3 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2753964 | usd |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
2753964 | usd | |
CY2024Q3 | SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
11678 | usd |
SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
-150994 | usd | |
SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
471400 | usd | |
SDST |
Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
|
955000 | usd | |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-1111347 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-65345 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2702498 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-925932 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10092312 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-843800 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14185887 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2828585 | usd | |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.22 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.34 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.22 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.34 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45171254 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40453289 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
41694909 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40367188 | shares | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
45171254 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40453289 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
41694909 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40367188 | shares | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
90 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
90 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-245505 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-245415 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1984695 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-843800 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2828495 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
90 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
90 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2828585 | usd | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-2828495 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1399213 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
59599 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
100 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2694362 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
58125 | usd |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
100 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-7710413 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10092312 | usd |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
6916355 | usd |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
783 | usd |
CY2024Q3 | SDST |
Stock Issued During Period Shares Issued Upon Conversion Of Safes
StockIssuedDuringPeriodSharesIssuedUponConversionOfSafes
|
6367200 | usd |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2571400 | usd |
CY2024Q3 | SDST |
Issuance Of Common Stock Upon Reverse Capitalization
IssuanceOfCommonStockUponReverseCapitalization
|
5483019 | usd |
CY2024Q3 | SDST |
Stock Issued During Period Shares Issued Upon Exercise Of Common Stock Warrants
StockIssuedDuringPeriodSharesIssuedUponExerciseOfCommonStockWarrants
|
1626619 | usd |
CY2024Q3 | SDST |
Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
|
7501223 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13304610 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3734762 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14185887 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
7034079 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
|
983 | usd | |
SDST |
Stock Issued During Period Shares Issued Upon Exercise Of Common Stock Warrants
StockIssuedDuringPeriodSharesIssuedUponExerciseOfCommonStockWarrants
|
1626619 | usd | |
SDST |
Stock Issued During Period Shares Issued Upon Conversion Of Safe
StockIssuedDuringPeriodSharesIssuedUponConversionOfSafe
|
6367200 | usd | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2571400 | usd | |
SDST |
Issuance Of Common Stock Upon Reverse Capitalization
IssuanceOfCommonStockUponReverseCapitalization
|
5483019 | usd | |
SDST |
Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
|
7501223 | usd | |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13304610 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13304610 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14185887 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2828585 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7034079 | usd | |
SDST |
Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
|
-150994 | usd | |
SDST |
Fair Value Of Simple Agreement For Future Equity Issuance Costs
FairValueOfSimpleAgreementForFutureEquityIssuanceCosts
|
955000 | usd | |
SDST |
Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
|
2753964 | usd | |
SDST |
Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
|
471400 | usd | |
SDST |
Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
|
1636100 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1074 | usd | |
SDST |
Safe Notes Issuance Costs
SafeNotesIssuanceCosts
|
466302 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
461575 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
15000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-4055728 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
733998 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
458618 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
|
11240 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
49616 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8514161 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1582429 | usd | |
SDST |
Payments For Preacquisition Land Cost
PaymentsForPreacquisitionLandCost
|
726102 | usd | |
SDST |
Payments For Preacquisition Land Cost
PaymentsForPreacquisitionLandCost
|
25000 | usd | |
us-gaap |
Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
|
50000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
11155 | usd | |
SDST |
Payments To Promissory Note Issued
PaymentsToPromissoryNoteIssued
|
492000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1279257 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-25000 | usd | |
SDST |
Proceeds From Investor For Issuance Of Safe Notes
ProceedsFromInvestorForIssuanceOfSafeNotes
|
200000 | usd | |
SDST |
Proceeds From Investor For Issuance Of Safe Notes
ProceedsFromInvestorForIssuanceOfSafeNotes
|
2000000 | usd | |
SDST |
Proceeds From Investor Deposits
ProceedsFromInvestorDeposits
|
1000000 | usd | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1000000 | usd | |
us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
1000000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
90 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
1561655 | usd | |
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
2100000 | usd | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
4134056 | usd | |
SDST |
Payment Of Safe Note Issuance Cost To Related Parties
PaymentOfSafeNoteIssuanceCostToRelatedParties
|
435000 | usd | |
us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
510000 | usd | |
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
199170 | usd | |
SDST |
Proceeds From Business Combination And Issuance Of Pipe Shares
ProceedsFromBusinessCombinationAndIssuanceOfPIPEShares
|
11639088 | usd | |
SDST |
Repayment Of Sponsor Promissory Notes
RepaymentOfSponsorPromissoryNotes
|
1562834 | usd | |
SDST |
Repurchase Of Unvested Shares
RepurchaseOfUnvestedShares
|
6003 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
10108680 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2565090 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
315262 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
957661 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1271824 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1587086 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
957661 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
8814 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
7111 | usd | |
SDST |
Unpaid Deferred Transaction Cost
UnpaidDeferredTransactionCost
|
3470991 | usd | |
SDST |
Conversion Of Legacy Safe Notes
ConversionOfLegacySafeNotes
|
64 | usd | |
SDST |
Conversion Of Legacy Convertible Notes
ConversionOfLegacyConvertibleNotes
|
26 | usd | |
SDST |
Sponsor Earn Out Share Liability
SponsorEarnOutShareLiability
|
4608900 | usd | |
SDST |
Issuance Of Common Stock To Sponsor
IssuanceOfCommonStockToSponsor
|
400 | usd | |
SDST |
Net Liabilities Assumed Upon Closing Of Business Combination
NetLiabilitiesAssumedUponClosingOfBusinessCombination
|
14638315 | usd | |
SDST |
Issuance Of Common Stock To Non Redeeming Shareholders
IssuanceOfCommonStockToNonRedeemingShareholders
|
13 | usd | |
SDST |
Unpaid Safe Note Issuance Costs
UnpaidSafeNoteIssuanceCosts
|
31302 | usd | |
SDST |
Unpaid Preacquisition Capital Project Cost
UnpaidPreacquisitionCapitalProjectCost
|
846385 | usd | |
CY2024Q3 | SDST |
Battery Grade Lithum Number Of Units
BatteryGradeLithumNumberOfUnits
|
50000 | |
CY2023Q4 | SDST |
Ordinary Shares Issued At Closing Of Business Combination
OrdinarySharesIssuedAtClosingOfBusinessCombination
|
127777 | shares |
CY2024Q3 | us-gaap |
Share Price
SharePrice
|
10.00 | |
CY2023Q4 | SDST |
Business Acquisition Trading Days
BusinessAcquisitionTradingDays
|
P20D | |
CY2023Q4 | SDST |
Business Acquisition Consecutive Trading Days
BusinessAcquisitionConsecutiveTradingDays
|
P30D | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_843_eus-gaap--UseOfEstimates_zbRFufYql52c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zPqnErhNcFF2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the unaudited condensed consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, useful life of computer and equipment, realization of deferred tax assets, fair valuation of investment in equity securities and fair valuation of stock based compensation, warrants, simple agreement for future equity notes (each a “SAFE note”), convertible notes and earnout shares. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> | ||
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10092312 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14185887 | usd | |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-43050972 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-13304610 | usd |
CY2024Q3 | us-gaap |
Cash
Cash
|
1587086 | usd |
CY2024Q3 | us-gaap |
Other Investments
OtherInvestments
|
10075002 | usd |
CY2024Q3 | SDST |
Trust Account Proceeds Net
TrustAccountProceedsNet
|
1564086 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-10092312 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-843800 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14185887 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2828585 | usd | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
45171254 | shares |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
45171254 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40453289 | shares |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40453289 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
41694909 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
41694909 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40367188 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40367188 | shares | |
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.22 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.22 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.02 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.02 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.34 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.34 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.07 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.07 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
125411 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
893985 | shares | |
SDST |
Antidilutive Securities Excluded From Computation Of Restricted Stock Options
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockOptions
|
851655 | shares | |
SDST |
Antidilutive Securities Excluded From Computation Of Restricted Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockUnits
|
3281911 | shares | |
SDST |
Antidilutive Securities Excluded From Computation Of Performance Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfPerformanceStockUnits
|
506596 | shares | |
SDST |
Antidilutive Securities Excluded From Computation Of Public Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPublicWarrants
|
4864133 | shares | |
SDST |
Antidilutive Securities Excluded From Computation Of Private Placement Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPrivatePlacementWarrants
|
5566667 | shares | |
CY2023Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
1005109 | usd |
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
6496114 | usd | |
CY2023Q4 | SDST |
Equity Classified Instruments
EquityClassifiedInstruments
|
7501223 | usd |
CY2024Q3 | us-gaap |
Deferred Costs
DeferredCosts
|
199724 | usd |
CY2023Q2 | SDST |
Nonrefundable Payment
NonrefundablePayment
|
25000 | usd |
CY2023Q4 | SDST |
Nonrefundable Payment
NonrefundablePayment
|
75000 | usd |
CY2024Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1562030 | usd |
CY2024Q2 | SDST |
Debt Instrument Payment For First Non Refundable Extension Payment
DebtInstrumentPaymentForFirstNonRefundableExtensionPayment
|
33333 | usd |
CY2024Q3 | SDST |
Debt Instrument Payment For First Non Refundable Extension Payment
DebtInstrumentPaymentForFirstNonRefundableExtensionPayment
|
33333 | usd |
SDST |
Capital Project Costs
CapitalProjectCosts
|
1770821 | usd | |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
47736650 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
SDST |
Fair Value Of Earnout Share Arrangement Amount
FairValueOfEarnoutShareArrangementAmount
|
25071000 | usd | |
CY2024Q3 | SDST |
Net Cash Proceeds Received From Reverse Recapitalization And Pipe Financing
NetCashProceedsReceivedFromReverseRecapitalizationAndPipeFinancing
|
9154761 | usd |
CY2024Q3 | us-gaap |
Cash Acquired From Acquisition
CashAcquiredFromAcquisition
|
1564086 | usd |
CY2024Q3 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
10075002 | usd |
CY2024Q3 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
921493 | usd |
CY2024Q3 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1562834 | usd |
CY2024Q3 | SDST |
Net Cash Proceeds Received From Reverse Recapitalization And Pipe Financing
NetCashProceedsReceivedFromReverseRecapitalizationAndPipeFinancing
|
9154761 | usd |
CY2024Q3 | us-gaap |
Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
|
14638215 | usd |
CY2024Q3 | SDST |
Adjustments To Additional Paid In Capital Business Combination
AdjustmentsToAdditionalPaidInCapitalBusinessCombination
|
-5483454 | usd |
CY2024Q3 | SDST |
Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
|
7501223 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
|
As part of the closing of the Business Combination, the Company issued 1,000,000 shares to Global Partner Sponsor II, LLC (the “Sponsor”). These shares are subject to vesting (or forfeiture) based on achieving certain trading price thresholds following the closing (“Sponsor Earnout Shares”). Fifty percent of the Sponsor Earnout Shares will vest when the VWAP of the Common Stock price equals or exceeds $12.00 per share for a period of 20 trading days in a 30 trading day period, and the remaining fifty percent of the Sponsor Earnout Shares will vest when the VWAP of the Common Stock price equals or exceeds $14.00 per share for a period of 20 trading days in a 30 trading day period. There are no service conditions or any requirement for the participants to provide goods or services in order to vest in the Sponsor Earnout Shares. Accordingly, we determined that the Sponsor Earnout Shares are not within the scope of ASC 718. The accounting for the Sponsor Earnout Shares was evaluated under ASC Topic 480, “Distinguishing Liabilities from Equity”, and ASC Subtopic 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, to determine if the Sponsor Earnout Shares should be classified as a liability or within equity. As part of the analysis, it was determined that the Sponsor Earnout Shares subject to vesting are freestanding from other shares of Combined Company Common Stock held by the Sponsor and do not meet the criteria in ASC 815-40 to be considered indexed to the Combined Company Common Stock, due to the settlement provisions including a change in control component which could impact the number of the Sponsor Earnout Shares are ultimately settled for, which is not an input to a fixed-for-fixed option pricing model. As a result, the Sponsor Earnout Shares will be classified as a liability. Subsequent changes in the fair value of the Sponsor Earnout shares will be reflected in the consolidated statement of operations. | ||
CY2024Q3 | SDST |
Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
|
2972800 | usd |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
700000000 | shares |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
100000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
47872445 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41499772 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41499772 | shares |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
2531232 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
1191980 | shares |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P24M | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
125411 | shares |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P0Y6M | ||
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
313528 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.000002 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
|
188117 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
|
0.000002 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
|
125411 | shares |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.000002 | |
CY2023Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
2301120 | shares |
CY2024Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
0 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2278108 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2278108 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.0065 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.0065 | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
14850 | usd | |
CY2023Q4 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
920448 | shares |
CY2023Q4 | us-gaap |
Sale Of Stock Price Per Share
SaleOfStockPricePerShare
|
0.0065 | |
CY2023Q4 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
6000 | usd |
SDST |
Shares Exercised Outstanding
SharesExercisedOutstanding
|
7667 | usd | |
SDST |
Shares Exercised Outstanding
SharesExercisedOutstanding
|
8650 | usd | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1326979 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.57 | |
SDST |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross
|
-219644 | shares | |
SDST |
Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
|
0.57 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
255680 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.60 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
851655 | shares |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.56 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
0.60 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
0.70 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.0384 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0386 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | pure | |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
10430800 | shares |
CY2024Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
11.50 | |
SDST |
Class Of Warrant Or Rights Description
ClassOfWarrantOrRightsDescription
|
Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Common Stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Public Warrant holders, and that certain other conditions are met. Once the Public Warrants become exercisable, the Company may also redeem the outstanding Public Warrants in whole and not in part at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the closing price of the common stock equals or exceeds $10.00 per share on the trading day prior to the date on which the Company sends the notice of redemption, and that certain other conditions are met. If the closing price of the common stock is less than $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders, the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants. | ||
CY2023Q4 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
218556 | usd |
CY2023Q4 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
218556 | usd |
CY2024Q3 | us-gaap |
Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
|
67562 | usd |
CY2024Q3 | us-gaap |
Assets Fair Value Disclosure
AssetsFairValueDisclosure
|
67562 | usd |
CY2023Q4 | us-gaap |
Liabilities Related To Investment Contracts Fair Value Disclosure
LiabilitiesRelatedToInvestmentContractsFairValueDisclosure
|
5212200 | usd |
CY2023Q4 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
5212200 | usd |
CY2024Q3 | SDST |
Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
|
2972800 | usd |
CY2024Q3 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
2972800 | usd |
CY2023Q3 | SDST |
Consulting Expenses
ConsultingExpenses
|
147497 | usd |
SDST |
Consulting Expenses
ConsultingExpenses
|
1306935 | usd | |
us-gaap |
Other Expenses
OtherExpenses
|
44186 | usd | |
CY2023Q3 | SDST |
Consulting And Other Expense
ConsultingAndOtherExpense
|
147497 | usd |
SDST |
Consulting And Other Expense
ConsultingAndOtherExpense
|
1351121 | usd | |
SDST |
Capital Contribution In Exchange Of Subscription
CapitalContributionInExchangeOfSubscription
|
90 | usd | |
CY2023Q2 | SDST |
Capital Contribution In Exchange Of Subscription
CapitalContributionInExchangeOfSubscription
|
90 | usd |
us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
1000000 | usd | |
us-gaap |
Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
|
1000000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
7111 | usd | |
CY2024Q3 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
1053345 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
|
151284 | usd |
CY2024Q3 | SDST |
Advisory Fees
AdvisoryFees
|
3000000 | usd |
CY2024Q3 | us-gaap |
Other Liabilities
OtherLiabilities
|
75913 | usd |
CY2023Q4 | us-gaap |
Other Liabilities
OtherLiabilities
|
56823 | usd |
CY2024Q3 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
4129258 | usd |
CY2023Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
208107 | usd |